English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe Dhillon family seemed to be living the California dream, enjoying the waterway just steps from their home on Naples Island. But a little more than five years ago, when their daughter, Daya, began feeling ill, the Dhillon family’s California dream morphed into a medical nightmare.
Tag: Cedars-Sinai
MEDIA ADVISORY: Cedars-Sinai Physicians, Scientists Featured at Otolaryngology-Head and Neck Surgery Conference
Physicians and scientists from Cedars-Sinai will be attending and sharing research and clinical breakthroughs at the American Rhinologic Society Annual Meeting (ARS) taking place Sept. 9-10, the American Neurotology Society (ANS) “Super Saturday” Meeting Sept. 10, and the American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting (AAO-HNSF22) taking place Sept. 10-14, in Philadelphia.
Cedars-Sinai Medical Network Selects Jill Martin as Executive Vice President
Jill Martin has been tapped to lead the Cedars-Sinai Medical Network as its new executive vice president, effective Nov. 30.
Summer Research Highlights
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
Cedars-Sinai Study Highlights Cancer Disparities in LA County
People in Los Angeles County experience differences in cancer risk and survival depending on a variety of factors such as race/ethnicity, gender, sexual orientation, geographic location and socioeconomic status, according to a new study by investigators at Cedars-Sinai Cancer.
August Research Highlights
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
Cedars-Sinai Team Pioneers Liver Cancer Blood Test
Cedars-Sinai Cancer investigators have created a blood test that uses a technology made commonly available during the COVID-19 pandemic to detect the most common form of liver cancer—at an early enough stage that cure is possible. Their work was published online in the peer-reviewed journal Hepatology.
Guía Hacia la Resiliencia: Gestión del Estrés Prolongado
Después de dos años y medio de vivir la pandemia de COVID-19, el próximo fin de semana largo puede sentirse como un respiro del constante estrés, comenta el Dr. Itai Danovitch MBA, presidente del Departamento de Psiquiatría y Neurociencias del Comportamiento de Cedars-Sinai.
A Survivor’s Guide to Brain Cancer
Sheri Saenz is enjoying everyday pleasures as a Laguna Niguel grandmother, crafting and camping with her granddaughter and grandson and vacationing with her husband of 34 years.
Late-Breaking Heart Research: AI More Accurate Than Technicians
In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at Cedars-Sinai, artificial intelligence (AI) proved more successful in assessing and diagnosing cardiac function when compared to echocardiogram assessments made by sonographers.
The Truth About Monkeypox
Monkeypox cases are on the rise in the U.S., stoking fear and confusion about the way the virus is spread, who is at risk and where to seek treatment.
How Tumors Make Immune Cells ‘Go Bad’
Investigators from Cedars-Sinai Cancer have discovered that cancerous tumors called soft-tissue sarcomas produce a protein that switches immune cells from tumor-attacking to tumor-promoting. The study, published today in the peer-reviewed journal Cell Reports, could lead to improved treatments for soft-tissue sarcomas.
Health-Tech Startups Join Cedars-Sinai’s Eighth Accelerator Class
The Cedars-Sinai Accelerator is welcoming 10 health-tech startup companies from around the world to its eighth accelerator class. The companies are building a variety of healthcare solutions—from culturally-appropriate digital mental health services to wearable devices that help patients manage chronic asthma.
Genetic Score Detects Those at Risk for Sudden Cardiac Death
Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients at highest risk for developing sudden cardiac death—an electrical malfunction in the heart that causes it to stop beating.
Smidt Heart Institute Experts to Present Innovative Research Findings at European Society of Cardiology Congress 2022
Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and heart surgery programs, will present an array of innovative research—including late-breaking science—during the European Society of Cardiology Congress 2022, taking place in person and virtually Aug. 26-29.
Hyperactivation of the Immune System May Cause Post-COVID Syndromes
Investigators at Cedars-Sinai have proposed a theory for how SARS-CoV-2, the virus that causes COVID-19, infects the body. Their hypothesis, published in Frontiers in Immunology, could explain why some people still have symptoms long after the initial infection.
Q&A: Advice for a Healthy, Stress-Free Return to School
For the past two-plus years, the COVID-19 pandemic has disrupted children’s education and frustrated parents. Today, with the back-to-school season in full swing, Suzanne Silverstein, MA, ART, founding director of Cedars-Sinai Share & Care, and Rose Bisellach, RN, nurse manager in the Providence Cedars-Sinai Tarzana Medical Center Emergency Room, give their best advice for starting a successful school year.
International Leader in Autoimmune Research to Lead Cedars-Sinai Institute
Nunzio Bottini, MD, PhD, whose groundbreaking research focuses on the role of a group of proteins in the development of rheumatic diseases, has joined Cedars-Sinai as the inaugural director of the Kao Autoimmunity Institute.
New Method Detects Gut Microbes That Activate Immune Cells
Cedars-Sinai investigators have developed a method to help identify which human gut microbes are most likely to contribute to a slew of inflammatory diseases like obesity, liver disease, inflammatory bowel disease, cancer and some neurological diseases.
Play Ball! Cedars-Sinai Highlights Baseball Movie Art
As baseball heads into the final weeks of the regular season, Cedars-Sinai has opened a special exhibit, “Take Me Out to the Ball Game, 100+ Years of Baseball Movies & Entertainment.” It features hand-drawn posters of classic baseball-themed movies and, in all, consists of 35 items.
Radiation Oncology Expert Joins Cedars-Sinai Cancer
Marc Botnick, MD, a board-certified radiation oncologist with more than 20 years of experience managing all cancer types, has been named regional medical director for Radiation Oncology at Cedars-Sinai Cancer. His primary clinical practice site will be at Cedars-Sinai Tarzana Radiation Oncology, but he will work closely with physicians throughout the enterprise.
Cedars-Sinai Lung Transplant Outcomes Rated Outstanding
A new report on lung transplantation success rates confirms that Cedars-Sinai patients experienced one-year survival outcomes of 91.49%, an achievement above the national average of 89.46%.
COVID-19 Immunity Test Inventor: ‘It’s Not Just About Antibodies’
When it comes to COVID-19 immunity, antibodies do not tell the whole story, according to Cedars-Sinai professor of Medicine Stanley C. Jordan, MD.
Second Opinions and a Heroic Mother Lead to Second Chances at Life
Adelynn Garza knows a thing or two about beating the odds.
Stroke Biomarker, Health Equity Expert Joins Cedars-Sinai
Alexis Simpkins, MD, PhD, a stroke expert whose research focuses on acute stroke treatment and prevention, advanced brain imaging, and improving health equity in patient care and diversity among trainees in stroke, has joined the faculty in the Department of Neurology at Cedars-Sinai as director of Vascular Neurology Research and the Stroke RNA, Imaging, and Protein Predictors for Patient Tailored Treatments (SkRIPT) Program.
Standing Up to Stage 4 Breast Cancer
Holly Hammond faced one of the toughest-imaginable breast cancer scenarios. Her cancer was already advanced and had spread to her liver and lymph nodes when she discovered a tumor on her right breast. The tumor was negative for all of the markers that respond to targeted therapies for cancer treatment. She was also positive for the genes that mark her as especially prone to breast cancer.
Genetics May Predict Bladder Cancer Immunotherapy Response
Investigators from Cedars-Sinai Cancer have identified genetic signatures that could predict whether tumors in patients with bladder and other cancers will respond to immunotherapy. Their results, published today in the peer-reviewed Journal of the National Cancer Institute, could one day help guide clinicians to the most effective treatments for cancer patients.
New National Guidelines Aim to Prevent Obesity in Midlife Women
Women between 40 and 60 years old are the focus of new national guidelines aimed at preventing unhealthy weight gain that can lead to serious illness. The study review paper and clinical guidelines are published in the Annals of Internal Medicine.
Cedars-Sinai’s Howard Sandler, MD, Elected President of ASTRO
Howard Sandler, MD, chair of the Department of Radiation Oncology at Cedars-Sinai Cancer, has been named president-elect of the American Society for Radiation Oncology (ASTRO). Sandler will begin his term as president-elect in October, followed by single-year terms as president, chair and then immediate past chair of the ASTRO Board.
Preclinical Study: Antibiotics Affect Male and Female Gut Microbiomes Differently
In a new study, researchers at Cedars-Sinai found that antibiotics have sex-specific effects on the gut microbiome makeup of male and female laboratory rats. The findings, published in the journal Frontiers in Microbiology, could have implications for using the drugs in humans to treat or prevent bacterial infection.
Mazel Tov! Fourth Generation Born at Cedars-Sinai
When Arnold Paul was born at Kaspare Cohn Hospital in 1924, no one knew a family tradition was starting.
Hypertension Elevates Risk for More Severe COVID-19 Illness
Hypertension more than doubles the risk of hospitalization related to Omicron infection, even in people who are fully vaccinated and boosted, according to a new study led by investigators in the Smidt Heart Institute at Cedars-Sinai. The findings are published in the journal Hypertension.
Cedars-Sinai July Research Highlights
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
Cedars-Sinai Gives Record $36.5M to Los Angeles Community
Cedars-Sinai Medical Center has awarded a record $36.5 million in grants and sponsorships to nonprofit organizations throughout Los Angeles that are working to improve access to healthcare, civic engagement, social determinants of health and other nonmedical factors that influence health outcomes.
‘Grandparents Project’ Helps Teens Track Loved Ones’ Prescriptions
When Jason Lozada, 19, would open the medicine chest in his family’s shared bathroom, he would be concerned about the number of prescription bottles for his father, Vicente Lozada, 54, lining the shelves.
Cedars-Sinai Ranked #2 Hospital in Nation by U.S. News & World Report
Cedars-Sinai has been named the #2 hospital in the nation and #1 in California in U.S. News & World Report’s “Best Hospitals 2022-23” rankings.
Cedars-Sinai Transplant Clinicians Earn National Recognition
Two physician leaders from the Cedars-Sinai Comprehensive Transplant Center have been honored by two prestigious national groups.
A First Look at Cedars-Sinai Guerin Children’s
Inside the new, 23,000-square-foot Guerin Children’s, walls are painted in cheerful yellows, greens and blues. Artificial skylights are timed to brighten and darken as the sun rises and sets. Interactive-art installations feature whimsical characters, and a playroom and family lounge area contribute to the playful energy of the space.
A Lifetime of Heart Care Leads to Transplant
While many 21-year-olds celebrate their coming of age in bars and nightclubs, Andrew Solis is celebrating freedom by finally going home—equipped with a new heart and liver—after nearly eight months at Cedars-Sinai.
Cedars-Sinai Names David M. Wrigley as Chief Financial Officer
David M. Wrigley has been promoted to executive vice president and chief financial officer of Cedars-Sinai Health System, effective July 1.
Hormones Contribute to Sex Disparities in Bladder Cancer, Study Shows
Male sex hormones interfere with the body’s ability to fight bladder cancer, likely explaining why males experience higher cancer rates and more deadly disease, according to a new study co-led by a Cedars-Sinai Cancer investigator.
First-of-its-Kind Stem Cell and Gene Therapy Highlighted at Annual Stem Cell Meeting
Investigators from Cedars-Sinai will present the latest novel stem cell and regenerative medicine research at the International Society for Stem Cell Research (ISSCR) Annual Meeting, which is being held in person and virtually June 15-19 in San Francisco.
Black, Hispanic Patients Less Likely to Get Lifesaving Liver Cancer Treatment
Racial and ethnic minorities diagnosed with advanced liver cancer have a lower chance of receiving immunotherapy, the most effective treatment for patients with the disease, according to a new study led by Cedars-Sinai Cancer investigators.
Path to Remission for a Brain Cancer That Is Usually Fatal
Recently, Michael Wulfe, who is 61 and lives in West Hollywood, was on the phone with his sister, Stephanie Wulfe, in Dallas. They talk at least once a day, but that day, something wasn’t right. “I was talking, and then I didn’t have the words,” Wulfe said. “My sister immediately said, ‘Call Cedars-Sinai!’”
National Leader in Cardiac Surgery Quality and Research Joins Cedars-Sinai
Michael Bowdish, MD, MS, a national leader in cardiac surgery and among a handful of cardiac surgeons continuously funded by the National Institutes of Health for a decade, has been appointed vice chair of the Department of Cardiac Surgery in the Smidt Heart Institute.
ASCO22: Lung Cancer Therapy Could Help Patients Live Longer
Results of a Phase II clinical trial led by Cedars-Sinai Cancer investigators indicate that an immunotherapy drug combination could extend the lives of those diagnosed with advanced non-small cell lung cancer, one of the most common forms of lung cancer. The research was presented today during the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, with simultaneous publication in the peer-reviewed Journal of Clinical Oncology.
ENDO 2022 to Feature Cedars-Sinai Physicians and Scientists
Physicians and scientists from Cedars-Sinai will discuss the latest advances in treatment, care and research at the Endocrine Society’s annual meeting (ENDO 2022) in Atlanta, June 11-14.
Study: Counting Cancerous Lymph Nodes Is Best Predictor
Patients newly diagnosed with cancer typically focus on one question, eclipsing all others: “What is my prognosis?”
Brain Cell Activity Plays Critical Role in CNS Disorder Outcomes
Investigators at Cedars-Sinai have comprehensively mapped molecular activity in the brain and spinal cord that is responsible for regulating the body’s response to central nervous system (CNS) disorders such as Alzheimer’s, Huntington’s disease and spinal cord injuries.
SpaceX CRS-25 to Launch Stem Cells to Space on June 9
Cedars-Sinai and Space Tango are launching pilot-scale systems for the in-space production of stem cells to see if they can elevate the next generation of stem cell and gene therapies by harnessing the near-zero gravity conditions of spaceflight.